Thrivent Financial for Lutherans Has $4.71 Million Position in Corteva, Inc. $CTVA

Thrivent Financial for Lutherans lessened its position in shares of Corteva, Inc. (NYSE:CTVA) by 17.1% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 70,189 shares of the company’s stock after selling 14,455 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Corteva were worth $4,710,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Chilton Capital Management LLC increased its position in Corteva by 18.1% during the 3rd quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock valued at $30,119,000 after purchasing an additional 68,380 shares during the period. Drummond Knight Asset Management Pty Ltd acquired a new stake in Corteva during the 4th quarter valued at approximately $25,713,000. Truist Financial Corp increased its position in Corteva by 4.5% during the 3rd quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock valued at $21,771,000 after purchasing an additional 13,910 shares during the period. Alberta Investment Management Corp acquired a new position in Corteva in the third quarter valued at approximately $5,018,000. Finally, Avior Wealth Management LLC boosted its holdings in shares of Corteva by 464.7% during the 4th quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock worth $2,205,000 after buying an additional 27,075 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance

Shares of CTVA opened at $79.16 on Friday. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.63. The business’s fifty day moving average is $81.31 and its 200 day moving average is $73.92. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The stock has a market cap of $52.95 billion, a P/E ratio of 46.57, a P/E/G ratio of 2.41 and a beta of 0.59.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. During the same period last year, the business earned $1.13 EPS. Corteva’s quarterly revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. JPMorgan Chase & Co. cut shares of Corteva from an “overweight” rating to a “neutral” rating and raised their price target for the stock from $75.00 to $77.00 in a report on Thursday, February 5th. CICC Research lifted their price target on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. BNP Paribas Exane lifted their price target on shares of Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Finally, Berenberg Bank lifted their price target on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research note on Thursday, March 26th. Thirteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $88.14.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.